Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
03 2021
Historique:
received: 30 09 2019
accepted: 16 12 2020
pubmed: 27 1 2021
medline: 30 3 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

Cortical pathology contributes to chronic cognitive impairment of patients suffering from the neuroinflammatory disease multiple sclerosis (MS). How such gray matter inflammation affects neuronal structure and function is not well understood. In the present study, we use functional and structural in vivo imaging in a mouse model of cortical MS to demonstrate that bouts of cortical inflammation disrupt cortical circuit activity coincident with a widespread, but transient, loss of dendritic spines. Spines destined for removal show local calcium accumulations and are subsequently removed by invading macrophages or activated microglia. Targeting phagocyte activation with a new antagonist of the colony-stimulating factor 1 receptor prevents cortical synapse loss. Overall, our study identifies synapse loss as a key pathological feature of inflammatory gray matter lesions that is amenable to immunomodulatory therapy.

Identifiants

pubmed: 33495636
doi: 10.1038/s41593-020-00780-7
pii: 10.1038/s41593-020-00780-7
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-367

Commentaires et corrections

Type : CommentIn

Références

Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. Multiple sclerosis. N. Engl. J. Med. 378, 169–180 (2018).
pubmed: 29320652 pmcid: 6942519 doi: 10.1056/NEJMra1401483
Mahad, D. H., Trapp, B. D. & Lassmann, H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 14, 183–193 (2015).
pubmed: 25772897 doi: 10.1016/S1474-4422(14)70256-X
Damjanovic, D. et al. Hippocampal and deep gray matter nuclei atrophy is relevant for explaining cognitive impairment in MS: a multicenter study. Am. J. Neuroradiol. 38, 18–24 (2017).
pubmed: 27686487 pmcid: 7963669 doi: 10.3174/ajnr.A4952
Eshaghi, A. et al. Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann. Neurol. 83, 210–222 (2018).
pubmed: 29331092 pmcid: 5838522 doi: 10.1002/ana.25145
Scalfari, A. et al. The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis. Neurology 90, e2099–e2106 (2018).
doi: 10.1212/WNL.0000000000005685
Peterson, J. W., Bö, L., Mörk, S., Chang, A. & Trapp, B. D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389–400 (2001).
pubmed: 11558796 doi: 10.1002/ana.1123
Lagumersindez-Denis, N. et al. Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis. Acta Neuropathol. 134, 15–34 (2017).
pubmed: 28386765 pmcid: 5486638 doi: 10.1007/s00401-017-1706-x
Jürgens, T. et al. Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis. Brain 139, 39–46 (2016).
pubmed: 26667278 doi: 10.1093/brain/awv353
Albert, M. et al. Synaptic pathology in the cerebellar dentate nucleus in chronic multiple sclerosis. Brain Pathol. 27, 737–747 (2017).
pubmed: 27706868 pmcid: 8028945 doi: 10.1111/bpa.12450
Rose, T., Jaepel, J., Hübener, M. & Bonhoeffer, T. Cell-specific restoration of stimulus preference after monocular deprivation in the visual cortex. Science 352, 1319–1322 (2016).
pubmed: 27284193 doi: 10.1126/science.aad3358
Xu, T. et al. Rapid formation and selective stabilization of synapses for enduring motor memories. Nature 462, 915–919 (2009).
pubmed: 19946267 pmcid: 2844762 doi: 10.1038/nature08389
Kuchibhotla, K. V. et al. Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59, 214–225 (2008).
pubmed: 18667150 pmcid: 2578820 doi: 10.1016/j.neuron.2008.06.008
Merlini, M. et al. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer’s disease model. Neuron 101, 1099–1108.e6 (2019).
pubmed: 30737131 pmcid: 6602536 doi: 10.1016/j.neuron.2019.01.014
Merkler, D., Ernsting, T., Kerschensteiner, M., Brück, W. & Stadelmann, C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129, 1972–1983 (2006).
pubmed: 16714315 doi: 10.1093/brain/awl135
Gardner, C. et al. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats. Brain 136, 3596–3608 (2013).
pubmed: 24176976 doi: 10.1093/brain/awt279
Lodygin, D. et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature 566, 503–508 (2019).
pubmed: 30787438 doi: 10.1038/s41586-019-0964-2
Magliozzi, R. et al. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann. Neurol. 83, 739–755 (2018).
pubmed: 29518260 doi: 10.1002/ana.25197
Lucchinetti, C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188–2197 (2011).
pubmed: 22150037 pmcid: 3282172 doi: 10.1056/NEJMoa1100648
Dana, H. et al. Thy1-GCaMP6 transgenic mice for neuronal population imaging in vivo. PLoS ONE 9, e108697 (2014).
pubmed: 25250714 pmcid: 4177405 doi: 10.1371/journal.pone.0108697
Schain, A. J., Hill, R. A. & Grutzendler, J. Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy. Nat. Med. 20, 443–449 (2014).
pubmed: 24681598 pmcid: 3981936 doi: 10.1038/nm.3495
Siffrin, V. et al. In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33, 424–436 (2010).
pubmed: 20870176 doi: 10.1016/j.immuni.2010.08.018
Witte, M. E. et al. Calcium influx through plasma-membrane nanoruptures drives axon degeneration in a model of multiple sclerosis. Neuron 101, 615–624.e5 (2019).
pubmed: 30686733 pmcid: 6389591 doi: 10.1016/j.neuron.2018.12.023
Thestrup, T. et al. Optimized ratiometric calcium sensors for functional in vivo imaging of neurons and T lymphocytes. Nat. Methods 11, 175–182 (2014).
pubmed: 24390440 doi: 10.1038/nmeth.2773
Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533–1549 (2014).
pubmed: 25002752 pmcid: 4113947 doi: 10.1084/jem.20132477
Hagan, N. et al. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis. 11, 904 (2020).
pubmed: 33097690 pmcid: 7584629 doi: 10.1038/s41419-020-03084-7
Nissen, J. C., Thompson, K. K., West, B. L. & Tsirka, S. E. Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery. Exp. Neurol. 307, 24–36 (2018).
pubmed: 29803827 pmcid: 6380683 doi: 10.1016/j.expneurol.2018.05.021
Olmos-Alonso, A. et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology. Brain 139, 891–907 (2016).
pubmed: 26747862 pmcid: 4766375 doi: 10.1093/brain/awv379
Huang, D., Wang, J., Kivisakk, P., Rollins, B. J. & Ransohoff, R. M. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193, 713–725 (2001).
pubmed: 11257138 pmcid: 2193420 doi: 10.1084/jem.193.6.713
Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566–581.e9 (2017).
pubmed: 28930663 pmcid: 5719893 doi: 10.1016/j.immuni.2017.08.008
Calabrese, M. et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 135, 2952–2961 (2012).
pubmed: 23065788 doi: 10.1093/brain/aws246
Dutta, R. et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann. Neurol. 69, 445–454 (2011).
pubmed: 21446020 pmcid: 3073544 doi: 10.1002/ana.22337
Michailidou, I. et al. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann. Neurol. 77, 1007–1026 (2015).
pubmed: 25727254 doi: 10.1002/ana.24398
Terry, R. D. et al. Physical basis of cognitive alterations in alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580 (1991).
pubmed: 1789684 doi: 10.1002/ana.410300410
Busche, M. A. et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science 321, 1686–1689 (2008).
pubmed: 18802001 doi: 10.1126/science.1162844
Šišková, Z. et al. Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer’s disease. Neuron 84, 1023–1033 (2014).
pubmed: 25456500 doi: 10.1016/j.neuron.2014.10.024
Marinković, P. et al. In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model. Brain 142, 1051–1062 (2019).
pubmed: 30847469 doi: 10.1093/brain/awz035
Rocca, M. A. et al. Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology 74, 1252–1259 (2010).
pubmed: 20404306 doi: 10.1212/WNL.0b013e3181d9ed91
Kerschensteiner, M. et al. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J. Exp. Med. 200, 1027–1038 (2004).
pubmed: 15492125 pmcid: 2211840 doi: 10.1084/jem.20040452
Ellwardt, E. et al. Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis. Nat. Neurosci. 21, 1392–1403 (2018).
pubmed: 30258239 doi: 10.1038/s41593-018-0193-2
Jawaid, S. et al. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome. Glia 66, 789–800 (2018).
pubmed: 29274095 doi: 10.1002/glia.23284
Vasek, M. J. et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534, 538–543 (2016).
pubmed: 27337340 pmcid: 5452615 doi: 10.1038/nature18283
Di Liberto, G. et al. Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping. Cell 175, 458–471.e19 (2018).
pubmed: 30173917 doi: 10.1016/j.cell.2018.07.049
Murphy, K. L. et al. Synaptic alterations and immune response are sexually dimorphic in a non-pertussis toxin model of experimental autoimmune encephalomyelitis. Exp. Neurol. 323, 113061 (2020).
pubmed: 31499065 doi: 10.1016/j.expneurol.2019.113061
Hong, S. & Stevens, B. Microglia: phagocytosing to clear, sculpt, and eliminate. Dev. Cell 38, 126–128 (2016).
pubmed: 27459063 doi: 10.1016/j.devcel.2016.07.006
Hammond, J. W. et al. Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis. Brain Behav. Immun. 87, 739–750 (2020).
pubmed: 32151684 pmcid: 8698220 doi: 10.1016/j.bbi.2020.03.004
Werneburg, S. et al. Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity 52, 167–182.e7 (2020).
pubmed: 31883839 doi: 10.1016/j.immuni.2019.12.004
Tufail, Y. et al. Phosphatidylserine exposure controls viral innate immune responses by microglia. Neuron 93, 574–586.e8 (2017).
pubmed: 28111081 pmcid: 5600182 doi: 10.1016/j.neuron.2016.12.021
Andres, A. L. et al. NMDA receptor activation and calpain contribute to disruption of dendritic spines by the stress neuropeptide CRH. J. Neurosci. 33, 16945–16960 (2013).
pubmed: 24155300 pmcid: 3807024 doi: 10.1523/JNEUROSCI.1445-13.2013
Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75–82 (2019).
pubmed: 31316211 pmcid: 6731122 doi: 10.1038/s41586-019-1404-z
Tanabe, S., Saitoh, S., Miyajima, H., Itokazu, T. & Yamashita, T. Microglia suppress the secondary progression of autoimmune encephalomyelitis. Glia 67, 1694–1704 (2019).
pubmed: 31106910
Holtmaat, A. et al. Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat. Protoc. 4, 1128–1144 (2009).
pubmed: 19617885 pmcid: 3072839 doi: 10.1038/nprot.2009.89
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
pubmed: 22930834 pmcid: 5554542 doi: 10.1038/nmeth.2089
Rodriguez, A. et al. Automated reconstruction of three-dimensional neuronal morphology from laser scanning microscopy images. Methods 30, 94–105 (2003).
pubmed: 12695107 doi: 10.1016/S1046-2023(03)00011-2
Wearne, S. L. et al. New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales. Neuroscience 136, 661–680 (2005).
pubmed: 16344143 doi: 10.1016/j.neuroscience.2005.05.053
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2014); https://www.R-project.org .
Vogelstein, J. T. et al. Fast nonnegative deconvolution for spike train inference from population calcium imaging. J. Neurophysiol. 104, 3691–3704 (2010).
pubmed: 20554834 pmcid: 3007657 doi: 10.1152/jn.01073.2009
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Mahmmoud, R. R. et al. Spatial and working memory is linked to spine density and mushroom spines. PLoS ONE 10, e0139739 (2015).
pubmed: 26469788 pmcid: 4607435 doi: 10.1371/journal.pone.0139739
Chen, J. L. et al. Pathway-specific reorganization of projection neurons in somatosensory cortex during learning. Nat. Neurosci. 18, 1101–1108 (2015).
pubmed: 26098757 doi: 10.1038/nn.4046
Bacmeister, C. M. et al. Motor learning promotes remyelination via new and surviving oligodendrocytes. Nat. Neurosci. 23, 819–831 (2020).
pubmed: 32424285 pmcid: 7329620 doi: 10.1038/s41593-020-0637-3
Snaidero, N. et al. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156, 277–290 (2014).
pubmed: 24439382 pmcid: 4862569 doi: 10.1016/j.cell.2013.11.044

Auteurs

Mehrnoosh Jafari (M)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Adrian-Minh Schumacher (AM)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Nicolas Snaidero (N)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Institute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases, Munich, Germany.

Emily M Ullrich Gavilanes (EM)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Tradite Neziraj (T)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Virág Kocsis-Jutka (V)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Daniel Engels (D)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Tanja Jürgens (T)

Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.

Ingrid Wagner (I)

Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.

Juan Daniel Flórez Weidinger (JDF)

Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Bernstein Center for Computational Neuroscience, University of Göttingen, Göttingen, Germany.
Max Planck Institute for Experimental Medicine, Göttingen, Germany.
Center for Biostructural Imaging of Neurodegeneration, Göttingen, Germany.

Stephanie S Schmidt (SS)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.

Eduardo Beltrán (E)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Nellwyn Hagan (N)

Rare and Neurological Disease Research, Sanofi, Framingham, MA, USA.

Lisa Woodworth (L)

Rare and Neurological Disease Research, Sanofi, Framingham, MA, USA.

Dimitry Ofengeim (D)

Rare and Neurological Disease Research, Sanofi, Framingham, MA, USA.

Joseph Gans (J)

Translational Sciences Genomics, Sanofi, Framingham, MA, USA.

Fred Wolf (F)

Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Bernstein Center for Computational Neuroscience, University of Göttingen, Göttingen, Germany.
Max Planck Institute for Experimental Medicine, Göttingen, Germany.
Center for Biostructural Imaging of Neurodegeneration, Göttingen, Germany.
Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany.

Mario Kreutzfeldt (M)

Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.

Ruben Portugues (R)

Sensorimotor Control, Max Planck Institute of Neurobiology, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Doron Merkler (D)

Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland. doron.merkler@unige.ch.
Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland. doron.merkler@unige.ch.

Thomas Misgeld (T)

Institute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany. thomas.misgeld@tum.de.
German Center for Neurodegenerative Diseases, Munich, Germany. thomas.misgeld@tum.de.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. thomas.misgeld@tum.de.

Martin Kerschensteiner (M)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany. martin.kerschensteiner@med.uni-muenchen.de.
Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany. martin.kerschensteiner@med.uni-muenchen.de.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. martin.kerschensteiner@med.uni-muenchen.de.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH